[English] 日本語
Yorodumi Papers
- Database of articles cited by EMDB/PDB/SASBDB data -

+
Search query

Keywords
Structure methods
Author
Journal
IF

-
Structure paper

TitleImmune memory shapes human polyclonal antibody responses to H2N2 vaccination.
Journal, issue, pagesCell Rep, Vol. 43, Issue 5, Page 114171, Year 2024
Publish dateMay 28, 2024
AuthorsYuhe R Yang / Julianna Han / Hailee R Perrett / Sara T Richey / Alesandra J Rodriguez / Abigail M Jackson / Rebecca A Gillespie / Sarah O'Connell / Julie E Raab / Lauren Y Cominsky / Ankita Chopde / Masaru Kanekiyo / Katherine V Houser / Grace L Chen / Adrian B McDermott / Sarah F Andrews / Andrew B Ward /
PubMed AbstractInfluenza A virus subtype H2N2, which caused the 1957 influenza pandemic, remains a global threat. A recent phase 1 clinical trial investigating a ferritin nanoparticle vaccine displaying H2 ...Influenza A virus subtype H2N2, which caused the 1957 influenza pandemic, remains a global threat. A recent phase 1 clinical trial investigating a ferritin nanoparticle vaccine displaying H2 hemagglutinin (HA) in H2-naive and H2-exposed adults enabled us to perform comprehensive structural and biochemical characterization of immune memory on the breadth and diversity of the polyclonal serum antibody response elicited. We temporally map the epitopes targeted by serum antibodies after vaccine prime and boost, revealing that previous H2 exposure results in higher responses to the variable HA head domain. In contrast, initial responses in H2-naive participants are dominated by antibodies targeting conserved epitopes. We use cryoelectron microscopy and monoclonal B cell isolation to describe the molecular details of cross-reactive antibodies targeting conserved epitopes on the HA head, including the receptor-binding site and a new site of vulnerability deemed the medial junction. Our findings accentuate the impact of pre-existing influenza exposure on serum antibody responses post-vaccination.
External linksCell Rep / PubMed:38717904 / PubMed Central
MethodsEM (single particle)
Resolution20.0 Å
Structure data

EMDB-41514: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-1 week 0
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41515: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-1 at week 4
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41516: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-1 at week 16
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41517: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-1 at week 20
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41518: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-2 at week 0
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41519: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 2-1 at week 4
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41520: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-2 at week 16
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41521: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-2 at week 20
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41522: Polyclonal immune complex of fab binding the H2 HA from serum of subject 1-3 at week 20
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41541: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 3-3 at week 0
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41543: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 3-3 at week 16
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41544: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 3-3 at week 20
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41545: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-1 at week 0
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41546: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-1 at week 4
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41547: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-1 at week 16
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41548: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-1 at week 20
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41549: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-2 at week 0
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41550: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-2 at week 4
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41551: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-2 at week 16
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41552: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-2 at week 20
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41553: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-3 at week 0
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41554: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-3 at week 4
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41555: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-3 at week 16
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41556: Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-3 at week 20
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41557: Polyclonal immune complex of Fab binding the H1 HA from serum of subject 1-1 at week 0
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41558: Polyclonal immune complex of Fab binding the H1 HA from serum of subject 1-1 at week 4
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41559: Polyclonal immune complex of Fab binding the H1 HA from serum of subject 1-1 at week 16
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41560: Polyclonal immune complex of Fab binding the H1 HA from serum of subject 1-1 at week 20
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41561: Polyclonal immune complex of Fab binding the H1 HA from serum of subject 2-2 at week 0
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41562: Polyclonal immune complex of Fab binding the H1 HA from serum of subject 2-2 at week 4
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41563: Polyclonal immune complex of Fab binding the H1 HA from serum of subject 2-2 at week 16
Method: EM (single particle) / Resolution: 20.0 Å

EMDB-41564: Polyclonal immune complex of Fab binding the H1 HA from serum of subject 2-2 at week 20
Method: EM (single particle) / Resolution: 20.0 Å

Source
  • Homo sapiens (human)

+
About Yorodumi Papers

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242):Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi Papers

Database of articles cited by EMDB/PDB/SASBDB data

  • Database of articles cited by EMDB, PDB, and SASBDB entries
  • Using PubMed data

Related info.:EMDB / PDB / SASBDB / Yorodumi / EMN Papers / Changes in new EM Navigator and Yorodumi

Read more